Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion in Intensive Care Unit (ICU) Patients (MERO001)
This study has been completed.
Study NCT00891423   Information provided by Austin Health

First Received on April 30, 2009.   Last Updated on July 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sepsis
More general conditions related to this trial
Infection
Inflammation
Pathologic Processes
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
Meropenem short infusion
Meropenem extended infusion
Additional drug interventions recognized in this trial
Meropenem
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Austin Health


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services